Prostate Cancer and Prostatic Diseases This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Is time to castration resistant prostate cancer a potential intermediate end-point for time to metastasis among men initiating androgen deprivation therapy for non-metastatic prostate cancer with rapid PSA doubling time (<9 months)?
Prostate Cancer and Prostatic Diseases, Published online: 01 September 2022; doi:10.1038/s41391-022-00585-8Is time to castration resistant prostate cancer a potential intermediate end-point for time to metastasis among men initiating androgen deprivation therapy for non-metastatic prostate cancer with rapid PSA doubling time (<9 months)? (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - September 1, 2022 Category: Urology & Nephrology Authors: Zachary Klaassen Lauren Howard Christopher J. D. Wallis Jessica L. Janes Amanda De Hoedt William J. Aronson Thomas J. Polascik Christopher J. Amling Christopher J. Kane Matthew R. Cooperberg Martha K. Terris Yuan Wu Stephen J. Freedland Source Type: research

Composite urinary and sexual outcomes after Rezum: an analysis of predictive factors from an Italian multi-centric study
Prostate Cancer and Prostatic Diseases, Published online: 30 August 2022; doi:10.1038/s41391-022-00587-6Composite urinary and sexual outcomes after Rezum: an analysis of predictive factors from an Italian multi-centric study (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - August 30, 2022 Category: Urology & Nephrology Authors: Davide Campobasso Giampaolo Siena Paolo Chiodini Enrico Conti Francesco Franzoso Daniele Maruzzi Evangelista Martinelli Francesco Varvello Cosimo De Nunzio Riccardo Autorino Bhaskar Kumar Somani Giovanni Ferrari Luca Cindolo Source Type: research

Should LHRH therapy be continued in patients receiving abiraterone acetate?
Prostate Cancer and Prostatic Diseases, Published online: 26 August 2022; doi:10.1038/s41391-022-00584-9Should LHRH therapy be continued in patients receiving abiraterone acetate? (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - August 26, 2022 Category: Urology & Nephrology Authors: Loic Ah-Thiane St éphane Supiot Source Type: research

Risk of progression following a negative biopsy in prostate cancer active surveillance
Prostate Cancer and Prostatic Diseases, Published online: 25 August 2022; doi:10.1038/s41391-022-00582-xRisk of progression following a negative biopsy in prostate cancer active surveillance (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - August 25, 2022 Category: Urology & Nephrology Authors: Kerri Beckmann Aida Santaolalla Mikio Sugimoto Peter Carroll Jose Rubio Arnauld Villers Anders Bjartell Todd Morgan Prokar Dasgupta Mieke Van Hemelrijck Oussama Elhage Source Type: research

The differential diagnostic value of dual-phase 18F-DCFPyL PET/CT in prostate carcinoma: methodological issues
Prostate Cancer and Prostatic Diseases, Published online: 09 August 2022; doi:10.1038/s41391-022-00576-9The differential diagnostic value of dual-phase 18F-DCFPyL PET/CT in prostate carcinoma: methodological issues (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - August 9, 2022 Category: Urology & Nephrology Authors: Siamak Sabour Hadis Ghajari Source Type: research

Head-to-head comparison of 68Ga-PSMA-11 PET/CT and 68Ga-PSMA-11 PET/MRI in the detection of biochemical recurrence of prostate cancer: summary of head-to-head comparison studies
Prostate Cancer and Prostatic Diseases, Published online: 05 August 2022; doi:10.1038/s41391-022-00581-yHead-to-head comparison of 68Ga-PSMA-11 PET/CT and 68Ga-PSMA-11 PET/MRI in the detection of biochemical recurrence of prostate cancer: summary of head-to-head comparison studies (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - August 5, 2022 Category: Urology & Nephrology Authors: Huasong Huo Shurui Shen Ding He Bin Liu Fuwei Yang Source Type: research

The role of PSA density in the MRI pathway for prostate cancer diagnostics
Prostate Cancer and Prostatic Diseases, Published online: 26 July 2022; doi:10.1038/s41391-022-00579-6The role of PSA density in the MRI pathway for prostate cancer diagnostics (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - July 26, 2022 Category: Urology & Nephrology Authors: Hannes Cash Martin Schostak Source Type: research

Intensity of observation with active surveillance or watchful waiting in men with prostate cancer in the United States
Prostate Cancer and Prostatic Diseases, Published online: 26 July 2022; doi:10.1038/s41391-022-00580-zIntensity of observation with active surveillance or watchful waiting in men with prostate cancer in the United States (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - July 26, 2022 Category: Urology & Nephrology Authors: Bashir Al Hussein Al Awamlh Xian Wu Daniel A. Barocas Kelvin A. Moses Richard M. Hoffman Spyridon P. Basourakos Patrick Lewicki Woodson W. Smelser Camilo Arenas-Gallo Jonathan E. Shoag Source Type: research

Features of patients referring to the outpatient office due to benign prostatic hyperplasia: analysis of a national prospective cohort of 5815 cases
Prostate Cancer and Prostatic Diseases, Published online: 22 July 2022; doi:10.1038/s41391-022-00575-wFeatures of patients referring to the outpatient office due to benign prostatic hyperplasia: analysis of a national prospective cohort of 5815 cases (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - July 22, 2022 Category: Urology & Nephrology Authors: Paola Irene Ornaghi Angelo Porreca Marco Sandri Alessandro Sciarra Mario Falsaperla Giuseppe Mario Ludovico Maria Angela Cerruto Alessandro Antonelli Source Type: research

Single-port transvesical versus open simple prostatectomy: a perioperative comparative study
Prostate Cancer and Prostatic Diseases, Published online: 18 July 2022; doi:10.1038/s41391-022-00566-xSingle-port transvesical versus open simple prostatectomy: a perioperative comparative study (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - July 18, 2022 Category: Urology & Nephrology Authors: Mahmoud Abou Zeinab Aaron Kaviani Ethan Ferguson Alp T. Beksac Zeyad Schwen Bradley Gill Petar Bajic James Ulchaker Mohamed Eltemamy Jihad Kaouk Source Type: research

Editor’ summary: A paradigm shift in castration-resistant prostate cancer management
Prostate Cancer and Prostatic Diseases, Published online: 15 July 2022; doi:10.1038/s41391-022-00574-xEditor’ summary: A paradigm shift in castration-resistant prostate cancer management (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - July 15, 2022 Category: Urology & Nephrology Authors: Cosimo De Nunzio Andrew J. Amstrong Inge Van Oort Tanya Dorff Source Type: research

Correction: Survival outcomes in patients with chemotherapy-naive metastatic castration-resistant prostate cancer treated with enzalutamide or abiraterone acetate
Prostate Cancer and Prostatic Diseases, Published online: 15 July 2022; doi:10.1038/s41391-022-00578-7Correction: Survival outcomes in patients with chemotherapy-naive metastatic castration-resistant prostate cancer treated with enzalutamide or abiraterone acetate (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - July 15, 2022 Category: Urology & Nephrology Authors: Scott T. Tagawa Krishnan Ramaswamy Ahong Huang Jack Mardekian Neil M. Schultz Li Wang Rickard Sandin Stanislav Lechpammer Daniel J. George Source Type: research

Transperineal Targeted Microwave Ablation (TMA) of localized prostate cancer guided by MRI-Ultrasound fusion and organ-based tracking: a pilot study
Prostate Cancer and Prostatic Diseases, Published online: 14 July 2022; doi:10.1038/s41391-022-00577-8Transperineal Targeted Microwave Ablation (TMA) of localized prostate cancer guided by MRI-Ultrasound fusion and organ-based tracking: a pilot study (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - July 14, 2022 Category: Urology & Nephrology Authors: Peter Ka-Fung Chiu Chun-Hong Chan Chi-Hang Yee Sui-Yan Lau Jeremy Yuen-Chun Teoh Ho-Fai Wong Ka-Lun Lo Tsz-Yau Yuen Hiu-Yee Hung Carmen Chi-Min Cho Chi-Fai Ng Source Type: research

Correction to: Cardiovascular risk of gonadotropin-releasing hormone antagonist versus agonist in men with prostate cancer: an observational study in Taiwan
Prostate Cancer and Prostatic Diseases, Published online: 11 July 2022; doi:10.1038/s41391-022-00568-9Correction to: Cardiovascular risk of gonadotropin-releasing hormone antagonist versus agonist in men with prostate cancer: an observational study in Taiwan (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - July 11, 2022 Category: Urology & Nephrology Authors: Yu-Hsuan Joni Shao Jian-Hua Hong Chun-Kai Chen Chao-Yuan Huang Source Type: research

Clinical use of the mRNA urinary biomarker SelectMDx test for prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 09 July 2022; doi:10.1038/s41391-022-00562-1Clinical use of the mRNA urinary biomarker SelectMDx test for prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - July 9, 2022 Category: Urology & Nephrology Authors: Wieke C. H. Visser Hans de Jong Sandra Steyaert Willem J. G. Melchers Peter F. A. Mulders Jack A. Schalken Source Type: research